GEP20125605B - Application of imidazoquinoline derivatives for colon diseases treatment or prevention of colorectal carcinoma - Google Patents
Application of imidazoquinoline derivatives for colon diseases treatment or prevention of colorectal carcinomaInfo
- Publication number
- GEP20125605B GEP20125605B GEAP200811913A GEAP2008011913A GEP20125605B GE P20125605 B GEP20125605 B GE P20125605B GE AP200811913 A GEAP200811913 A GE AP200811913A GE AP2008011913 A GEAP2008011913 A GE AP2008011913A GE P20125605 B GEP20125605 B GE P20125605B
- Authority
- GE
- Georgia
- Prior art keywords
- prevention
- application
- colorectal carcinoma
- diseases treatment
- colon diseases
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title abstract 2
- 208000001333 Colorectal Neoplasms Diseases 0.000 title abstract 2
- 201000010989 colorectal carcinoma Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- RHKWIGHJGOEUSM-UHFFFAOYSA-N 3h-imidazo[4,5-h]quinoline Chemical class C1=CN=C2C(N=CN3)=C3C=CC2=C1 RHKWIGHJGOEUSM-UHFFFAOYSA-N 0.000 title 1
- 208000019399 Colonic disease Diseases 0.000 title 1
- 230000007850 degeneration Effects 0.000 abstract 1
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 abstract 1
- 229960002751 imiquimod Drugs 0.000 abstract 1
- 208000022131 polyp of large intestine Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US645908P | 2008-01-15 | 2008-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GEP20125605B true GEP20125605B (en) | 2012-08-10 |
Family
ID=40419193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP200811913A GEP20125605B (en) | 2008-01-15 | 2008-12-23 | Application of imidazoquinoline derivatives for colon diseases treatment or prevention of colorectal carcinoma |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8008319B2 (enExample) |
| EP (1) | EP2237780A1 (enExample) |
| JP (1) | JP2011509956A (enExample) |
| CN (1) | CN101909624A (enExample) |
| AU (1) | AU2008347400B2 (enExample) |
| BR (1) | BRPI0822002A2 (enExample) |
| CA (1) | CA2708559C (enExample) |
| EA (1) | EA018579B1 (enExample) |
| GE (1) | GEP20125605B (enExample) |
| IL (1) | IL205819A (enExample) |
| MX (1) | MX2010007699A (enExample) |
| NZ (1) | NZ586161A (enExample) |
| UA (1) | UA101339C2 (enExample) |
| WO (1) | WO2009089900A1 (enExample) |
| ZA (1) | ZA201003906B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012004706A (es) | 2009-10-22 | 2012-06-08 | Gilead Sciences Inc | Derivados de purina o deazapurina utiles para el tratamiento de (inter alia) infecciones virales. |
| CN103566377A (zh) | 2012-07-18 | 2014-02-12 | 上海博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| EP3092255A4 (en) | 2014-01-10 | 2017-09-20 | Birdie Biopharmaceuticals Inc. | Compounds and compositions for treating egfr expressing tumors |
| CA2954446A1 (en) | 2014-07-09 | 2016-01-14 | Shanghai Birdie Biotech, Inc. | Anti-pd-l1 combinations for treating tumors |
| CN112546238A (zh) | 2014-09-01 | 2021-03-26 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-pd-l1结合物 |
| CN115252792A (zh) | 2016-01-07 | 2022-11-01 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-egfr组合 |
| CN106943598A (zh) | 2016-01-07 | 2017-07-14 | 博笛生物科技（北京）有限公司 | 用于治疗肿瘤的抗-her2组合 |
| CN115554406A (zh) | 2016-01-07 | 2023-01-03 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-cd20组合 |
| CN118515666A (zh) | 2017-04-27 | 2024-08-20 | 博笛生物科技有限公司 | 2-氨基-喹啉衍生物 |
| KR20200019226A (ko) | 2017-06-23 | 2020-02-21 | 버디 바이오파마슈티칼즈, 인크. | 약학 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2078547C1 (ru) * | 1995-11-28 | 1997-05-10 | Центральный научно-исследовательский рентгено-радиологический институт МЗМП РФ | Способ лечения полипоза желудка и двенадцатиперстной кишки |
| UA74852C2 (en) * | 2000-12-08 | 2006-02-15 | 3M Innovative Properties Co | Urea-substituted imidazoquinoline ethers |
| WO2002053138A2 (en) * | 2001-01-02 | 2002-07-11 | Elisabeth Shanahan-Prendergast | Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens |
| US20060193789A1 (en) * | 2002-10-25 | 2006-08-31 | Foamix Ltd. | Film forming foamable composition |
| JP2007511575A (ja) * | 2003-11-21 | 2007-05-10 | ノバルティス アクチエンゲゼルシャフト | タンパク質キナーゼ阻害剤としての１ｈ−イミダゾキノリン誘導体 |
-
2008
- 2008-12-23 MX MX2010007699A patent/MX2010007699A/es active IP Right Grant
- 2008-12-23 EP EP08871156A patent/EP2237780A1/en not_active Withdrawn
- 2008-12-23 GE GEAP200811913A patent/GEP20125605B/en unknown
- 2008-12-23 JP JP2010542534A patent/JP2011509956A/ja active Pending
- 2008-12-23 AU AU2008347400A patent/AU2008347400B2/en not_active Ceased
- 2008-12-23 UA UAA201006372A patent/UA101339C2/ru unknown
- 2008-12-23 CA CA2708559A patent/CA2708559C/en not_active Expired - Fee Related
- 2008-12-23 EA EA201001164A patent/EA018579B1/ru not_active IP Right Cessation
- 2008-12-23 BR BRPI0822002A patent/BRPI0822002A2/pt not_active IP Right Cessation
- 2008-12-23 CN CN2008801223531A patent/CN101909624A/zh active Pending
- 2008-12-23 WO PCT/EP2008/011088 patent/WO2009089900A1/en not_active Ceased
- 2008-12-23 NZ NZ586161A patent/NZ586161A/en unknown
-
2009
- 2009-01-14 US US12/353,683 patent/US8008319B2/en not_active Expired - Fee Related
-
2010
- 2010-05-17 IL IL205819A patent/IL205819A/en not_active IP Right Cessation
- 2010-06-01 ZA ZA2010/03906A patent/ZA201003906B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008347400B2 (en) | 2014-12-11 |
| EA201001164A1 (ru) | 2010-12-30 |
| EA018579B1 (ru) | 2013-09-30 |
| NZ586161A (en) | 2012-05-25 |
| EP2237780A1 (en) | 2010-10-13 |
| ZA201003906B (en) | 2011-03-30 |
| CA2708559C (en) | 2015-10-06 |
| IL205819A0 (en) | 2010-11-30 |
| BRPI0822002A2 (pt) | 2015-10-13 |
| WO2009089900A1 (en) | 2009-07-23 |
| UA101339C2 (ru) | 2013-03-25 |
| US20090182005A1 (en) | 2009-07-16 |
| CA2708559A1 (en) | 2009-07-23 |
| CN101909624A (zh) | 2010-12-08 |
| MX2010007699A (es) | 2010-08-04 |
| US8008319B2 (en) | 2011-08-30 |
| JP2011509956A (ja) | 2011-03-31 |
| IL205819A (en) | 2013-02-28 |
| AU2008347400A1 (en) | 2009-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009006706A (es) | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. | |
| WO2008124660A3 (en) | Methods and compositions for the treatment of cancer | |
| EA201170531A1 (ru) | Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака | |
| GEP20156229B (en) | 5-alkynyl-pyrimidines | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| JO3419B1 (ar) | مركبات بيريدوبيرازين مضادة للسرطان من خلال تثبيط إنزيمات كيناز fgfr | |
| MX2009006627A (es) | Quinazolinas para la inhibicion de pdk1. | |
| EA201171367A1 (ru) | Винилиндазолильные соединения | |
| IL205819A0 (en) | Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives | |
| PL2322221T3 (pl) | Kompozycja farmaceutyczna do leczenia i zapobiegania raka | |
| JO2788B1 (en) | Amido phenoxyendazole compounds beneficial as C-MET inhibitors | |
| PT2529626T (pt) | Composições e métodos para tratamento ou prevenção do cancro do cólon | |
| WO2009092108A3 (en) | Biomarkers for the diagnosis and treatment of pancreatic cancer | |
| PH12013502370A1 (en) | Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases | |
| SI2229369T1 (sl) | Derivati 6,7-dialkoksi kinazolina, uporabni za zdravljenje motenj, povezanih z rakom | |
| CA2806614C (en) | Combinatory cancer treatment | |
| ME02017B (me) | Jedinjenja, kompozicije i postupci za tretman beta-amiloidnih bolesti i sinukleinopatija | |
| WO2009137251A3 (en) | Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings | |
| WO2010141956A3 (en) | Methods and compositions for the treatment of cancer | |
| PL2305300T3 (pl) | Kompozycja farmaceutyczna do leczenia i zapobiegania nowotworowi | |
| GEP20135818B (en) | Nitrogenated derivatives of pancratistatin | |
| PL2331092T3 (pl) | Sposoby i kompozycje do podawania 3-halopirogronianiu i związków pochodnych w leczeniu nowotworu | |
| GB2507700A (en) | Compositions and methods for treatment of metastatic cancer | |
| IL198202A0 (en) | Peptide-cytotoxic conjugates | |
| EP2124554A4 (en) | COMPOSITIONS AND METHODS FOR CANCER TREATMENT |